Year-End Report – January – December, 2023 Redsense Medical AB (publ)
October – December 2023 · Net sales amounted to kSEK 8,025 (8,027). · Operating loss, EBIT amounted to kSEK -927 (555). · Result after tax amounted to kSEK -950 (-2,297). · Earnings per share were SEK -0.07 (-0.16). Significant events during the period · On October 26, Redsense Nomination Committee for the 2024 Annual General Meeting was announced. · On December 23, Redsense notified the market that Chairman of the Board, Patrik Byhmer, passed away. Significant events after the period · On January 8, Redsense announced that Eva Walde was appointed new